TRIB - Trinity Biotech increases loan facility to fund potential acquisitions ongoing operations

• Diagnostic products company Trinity Biotech ( NASDAQ: TRIB ) has increased an existing loan facility to fund potential acquisitions and ongoing operations.
• The amended and restated senior secured term loan credit facility allows for an immediate $5M increase to its outstanding term loan, and provides for a $20M facility to fund potential acquisitions.
• The 48-month facility matures in January 2026, and accrues interest at an annual rate equal to 11.25% plus the greater of (a) Term SOFR Reference Rate and (b) one percent per annum.
• In connection with the increased term loan facility, the company has agreed to reprice 2.5M warrants, with the warrants now having a per ADS price of $1.071 compared to their initial per ADS exercise price of $1.30.
• Source: Press Release

For further details see: